16 September 2026 editorial review · Item
FreeStyle Libre 2 Plus: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: FreeStyle Libre 2 Plus
Scope and findings:
- Read 15-day sensor study and current US prescribing page. Supports age 2+, 15 days and minute streaming; Plus systems share sensor design. Regional app, reader and AID compatibility must be checked separately.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.